{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T14:43:34Z","timestamp":1793285014934,"version":"4.5.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["25\\u202FK02425"],"award-info":[{"award-number":["25\\u202FK02425"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP26am121031"],"award-info":[{"award-number":["JP26am121031"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.bcp.2026.118330","type":"journal-article","created":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:36:14Z","timestamp":1786116974000},"page":"118330","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"P2","title":["Circadian proteolysis by the E3 ubiquitin ligase gp78 controls CYP3A4 activity in human hepatocytes"],"prefix":"10.1016","volume":"253","author":[{"given":"Maseri","family":"Okawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-1011-067X","authenticated-orcid":false,"given":"Yuji","family":"Omata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-2598-4566","authenticated-orcid":false,"given":"Tomoaki","family":"Yamauchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0588-0302","authenticated-orcid":false,"given":"Akito","family":"Tsuruta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigehiro","family":"Ohdo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4849-2377","authenticated-orcid":false,"given":"Satoru","family":"Koyanagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2026.118330_b0005","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41392-022-00899-y","article-title":"Molecular regulations of circadian rhythm and implications for physiology and diseases","volume":"7","author":"Fagiani","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bcp.2026.118330_b0010","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/imm.13747","article-title":"Circadian rhythm regulation in the immune system","volume":"171","author":"Ding","year":"2024","journal-title":"Immunology"},{"key":"10.1016\/j.bcp.2026.118330_b0015","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1126\/science.280.5369.1564","article-title":"Role of the CLOCK protein in the mammalian circadian mechanism","volume":"280","author":"Gekakis","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.bcp.2026.118330_b0020","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0092-8674(00)81014-4","article-title":"mCRY1 and mCRY2 are essential components of the negative limb of the circadian clock feedback loop","volume":"98","author":"Kume","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2026.118330_b0025","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1046\/j.1365-2826.2003.01082.x","article-title":"DNA microarray analyses of circadian timing: the genomic basis of biological time","volume":"15","author":"Duffield","year":"2003","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/j.bcp.2026.118330_b0030","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.cub.2006.04.026","article-title":"Circadian orchestration of the hepatic proteome","volume":"16","author":"Reddy","year":"2006","journal-title":"Curr. Biol."},{"key":"10.1016\/j.bcp.2026.118330_b0035","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/nar\/gkn893","article-title":"Mouse period 2 mRNA circadian oscillation is modulated by PTB\u2013mediated rhythmic mRNA degradation","volume":"37","author":"Woo","year":"2009","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bcp.2026.118330_b0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/gb-2012-13-6-r54","article-title":"Regulation of alternative splicing by the circadian clock and food related cues","volume":"13","author":"McGlincy","year":"2012","journal-title":"Genome Biol."},{"key":"10.1016\/j.bcp.2026.118330_b0045","doi-asserted-by":"crossref","first-page":"3609","DOI":"10.1016\/j.jmb.2012.10.022","article-title":"Micro-Managing the Circadian Clock: the role of microRNAs in biological timekeeping","volume":"425","author":"Mehta","year":"2013","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bcp.2026.118330_b0050","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.jconrel.2023.10.049","article-title":"Implications of biological clocks in pharmacology and pharmacokinetics of antitumor drugs","volume":"364","author":"Ohdo","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bcp.2026.118330_b0055","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/MBP.0b013e32833c7308","article-title":"Administration-time-dependent effects of blood pressure-lowering medications: basis for the chronotherapy of hypertension","volume":"15","author":"Smolensky","year":"2010","journal-title":"Blood Press. Monit."},{"key":"10.1016\/j.bcp.2026.118330_b0060","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.molmed.2016.03.004","article-title":"Dosing-time makes the poison: circadian regulation and pharmacotherapy","volume":"22","author":"Dallmann","year":"2016","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.bcp.2026.118330_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.115185","article-title":"Recent advances in circadian-regulated pharmacokinetics and its implications for chronotherapy","volume":"203","author":"Yu","year":"2022","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2026.118330_b0070","doi-asserted-by":"crossref","first-page":"896","DOI":"10.3390\/cancers14040896","article-title":"Time-Dependent Efficacy of Checkpoint Inhibitor Nivolumab: results from a pilot Study in patients with Metastatic Non-Small-Cell Lung Cancer","volume":"14","author":"Karabou\u00e9","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bcp.2026.118330_b0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2024.113571","article-title":"Early morning immune checkpoint blockade and overall survival of patients with metastatic cancer: an In-depth chronotherapeutic study","volume":"199","author":"Catozzi","year":"2024","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.bcp.2026.118330_b0080","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-008011","article-title":"Impact of immunotherapy time-of-day infusion on survival and immunologic correlates in patients with metastatic renal cell carcinoma: a multicenter cohort analysis","volume":"12","author":"Patel","year":"2024","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.bcp.2026.118330_b0085","doi-asserted-by":"crossref","first-page":"463","DOI":"10.3892\/ol.2024.14596","article-title":"Efficacy of timing\u2011dependent infusion of nivolumab in patients with advanced gastric cancer","volume":"28","author":"Tanaka","year":"2024","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.bcp.2026.118330_b0090","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/j.1552-4604.1986.tb02919.x","article-title":"Temporal variation in triazolam pharmacokinetics and pharmacodynamics after oral administration","volume":"26","author":"Smith","year":"1986","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.bcp.2026.118330_b0095","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/j.1875-9114.1997.tb03056.x","article-title":"Time-dependent disposition of tacrolimus and its effect on endothelin-1 in liver allograft recipients","volume":"17","author":"Min","year":"1997","journal-title":"Pharmacother J Hum Pharmacol Drug Ther"},{"key":"10.1016\/j.bcp.2026.118330_b0100","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1097\/FPC.0b013e3282f12a61","article-title":"Molecular basis for rhythmic expression of CYP3A4 in serum-shocked HepG2 cells","volume":"17","author":"Takiguchi","year":"2007","journal-title":"Pharmacogenet. Genomics"},{"key":"10.1016\/j.bcp.2026.118330_b0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7554\/eLife.05005","article-title":"Predicting effective microRNA target sites in mammalian mRNAs","volume":"4","author":"Agarwal","year":"2015","journal-title":"Elife"},{"key":"10.1016\/j.bcp.2026.118330_b0110","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1261\/rna.939908","article-title":"Normalization of microRNA expression levels in quantitative RT-PCR assays: Identification of suitable reference RNA targets in normal and cancerous human solid tissues","volume":"14","author":"Peltier","year":"2008","journal-title":"RNA"},{"key":"10.1016\/j.bcp.2026.118330_b0115","doi-asserted-by":"crossref","first-page":"14422","DOI":"10.1073\/pnas.251401598","article-title":"The tumor autocrine motility factor receptor, gp78, is a ubiquitin protein ligase implicated in degradation from the endoplasmic reticulum","volume":"98","author":"Fang","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bcp.2026.118330_b0120","doi-asserted-by":"crossref","first-page":"15655","DOI":"10.1073\/pnas.232137699","article-title":"Infection of a human hepatoma cell line by hepatitis B virus","volume":"99","author":"Gripon","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bcp.2026.118330_b0125","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.cbi.2006.12.003","article-title":"The human hepatoma HepaRG cells: a highly differentiated model for studies of liver metabolism and toxicity of xenobiotics","volume":"168","author":"Guillouzo","year":"2007","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.bcp.2026.118330_b0130","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1124\/dmd.107.016816","article-title":"Effect of commonly used organic solvents on the kinetics of cytochrome P450 2B6- and 2C8-dependent activity in human liver microsomes","volume":"35","author":"Vuppugalla","year":"2007","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bcp.2026.118330_b0135","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1126\/science.289.5488.2344","article-title":"Resetting of circadian time in peripheral tissues by glucocorticoid signaling","volume":"289","author":"Balsalobre","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.bcp.2026.118330_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2020.109904","article-title":"Translating around the clock: Multi-level regulation of post-transcriptional processes by the circadian clock","volume":"80","author":"Parnell","year":"2021","journal-title":"Cell. Signal."},{"key":"10.1016\/j.bcp.2026.118330_b0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0065300","article-title":"Role of miR-142-3p in the Post-Transcriptional Regulation of the Clock Gene Bmal1 in the Mouse SCN","volume":"8","author":"Shende","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bcp.2026.118330_b0150","doi-asserted-by":"crossref","unstructured":"Du N-H, Arpat AB, Matos MD, Gatfield D. MicroRNAs shape circadian hepatic gene expression on a transcriptome-wide scale. eLife 3, 2014.","DOI":"10.7554\/eLife.02510"},{"key":"10.1016\/j.bcp.2026.118330_b0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7554\/eLife.05005","article-title":"Predicting effective microRNA target sites in mammalian mRNAs","volume":"4","author":"Agarwal","year":"2015","journal-title":"Elife"},{"key":"10.1016\/j.bcp.2026.118330_b0160","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1124\/dmd.109.027680","article-title":"MicroRNAs regulate CYP3A4 expression via direct and indirect targeting","volume":"37","author":"Pan","year":"2009","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bcp.2026.118330_b0165","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.apsb.2018.12.002","article-title":"Bioengineered miR-27b-3p and miR-328-3p modulate drug metabolism and disposition via the regulation of target ADME gene expression","volume":"9","author":"Li","year":"2019","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.bcp.2026.118330_b0170","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1093\/nar\/gkn018","article-title":"Detection of a circadian enhancer in the mDbp promoter using prokaryotic transposon vector-based strategy","volume":"36","author":"Kiyohara","year":"2008","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bcp.2026.118330_b0175","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1124\/mol.105.021816","article-title":"Endoplasmic reticulum-associated degradation of cytochrome P450 CYP3A4 in Saccharomyces cerevisiae: further characterization of cellular participants and structural determinants","volume":"69","author":"Liao","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bcp.2026.118330_b0180","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.molcel.2005.08.009","article-title":"Gp78, a membrane-anchored ubiquitin ligase, associates with Insig-1 and couples sterol-regulated ubiquitination to degradation of HMG CoA reductase","volume":"19","author":"Song","year":"2005","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bcp.2026.118330_b0185","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1038\/nm1686","article-title":"The ubiquitin ligase gp78 promotes sarcoma metastasis by targeting KAI1 for degradation","volume":"13","author":"Tsai","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.bcp.2026.118330_b0190","doi-asserted-by":"crossref","first-page":"4268","DOI":"10.1093\/hmg\/ddp380","article-title":"Gp78, an ER associated E3, promotes SOD1 and ataxin-3 degradation","volume":"18","author":"Ying","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bcp.2026.118330_b0195","doi-asserted-by":"crossref","first-page":"549","DOI":"10.4161\/cbt.11.6.14834","article-title":"CHIP and gp78-mediated ubiquitination of CYP3A4: Implications for the pharmacology of anticancer agents","volume":"11","author":"Peer","year":"2011","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.bcp.2026.118330_b0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fncel.2017.00259","article-title":"Gp78 E3 ubiquitin ligase: Essential functions and contributions in proteostasis","volume":"11","author":"Joshi","year":"2017","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.bcp.2026.118330_b0205","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1073\/pnas.0506618103","article-title":"The activity of a human endoplasmic reticulum-associated degradation E3, gp78, requires its Cue domain, RING finger, and an E2-binding site","volume":"103","author":"Chen","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bcp.2026.118330_b0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s42003-019-0607-z","article-title":"Bmal1 regulates circadian expression of cytochrome P450 3a11 and drug metabolism in mice","volume":"2","author":"Lin","year":"2019","journal-title":"Commun. Biol."},{"key":"10.1016\/j.bcp.2026.118330_b0215","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.pharmthera.2012.12.007","article-title":"Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation","volume":"138","author":"Zanger","year":"2013","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bcp.2026.118330_b0220","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1016\/j.biomaterials.2013.11.063","article-title":"Molecular mechanisms underlying the enhanced functions of three-dimensional hepatocyte aggregates","volume":"35","author":"Chang","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.bcp.2026.118330_b0225","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adf2982","article-title":"Mice with humanized livers reveal the role of hepatocyte clocks in rhythmic behavior","volume":"9","author":"Delb\u00e8s","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.bcp.2026.118330_b0230","article-title":"Time-of-day-dependent variation of the human liver transcriptome and metabolome is disrupted in MASLD","volume":"6","author":"Johanns","year":"2023","journal-title":"JHEP Rep."},{"key":"10.1016\/j.bcp.2026.118330_b0235","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ejphar.2005.02.022","article-title":"Cyclic AMP-independent activation of CYP3A4 gene expression by forskolin","volume":"512","author":"Dowless","year":"2005","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bcp.2026.118330_b0240","doi-asserted-by":"crossref","first-page":"35866","DOI":"10.1074\/jbc.M110.167189","article-title":"Liver Cytochrome P450 3A Ubiquitination in vivo by gp78\/autocrine motility factor receptor and c terminus of hsp70-interacting protein (CHIP) E3 ubiquitin ligases","volume":"285","author":"Kim","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2026.118330_b0245","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.cell.2013.01.054","article-title":"FBXL21 regulates oscillation of the circadian clock through ubiquitination and stabilization of cryptochromes","volume":"152","author":"Hirano","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2026.118330_b0250","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.bbrc.2009.10.045","article-title":"Targeting of gp78 for ubiquitin-mediated proteasomal degradation by Hrd1: Cross-talk between E3s in the endoplasmic reticulum","volume":"390","author":"Shmueli","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bcp.2026.118330_b0255","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.18632\/oncotarget.1478","article-title":"Polyubiquitylation of AMF requires cooperation between the gp78 and TRIM25 ubiquitin ligases","volume":"5","author":"Wang","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.bcp.2026.118330_b0260","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.apsb.2019.11.002","article-title":"Cytochrome P450 endoplasmic reticulum-associated degradation (ERAD): therapeutic and pathophysiological implications","volume":"10","author":"Kwon","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.bcp.2026.118330_b0265","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1007\/s002280050708","article-title":"Circadian variation of the urinary 6\u03b2-hydroxycortisol to cortisol ratio that would reflect hepatic CYP3A activity","volume":"55","author":"Ohno","year":"2000","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.bcp.2026.118330_b0270","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1124\/dmd.31.11.1283","article-title":"Evidence for the validity of cortisol 6\u03b2-hydroxylation clearance as a new index for in vivo cytochrome P450 3A phenotyping in humans","volume":"31","author":"Furuta","year":"2003","journal-title":"Drug Metab. Dispos."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226006696?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226006696?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T20:12:31Z","timestamp":1788811951000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295226006696"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":54,"alternative-id":["S0006295226006696"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118330","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Circadian proteolysis by the E3 ubiquitin ligase gp78 controls CYP3A4 activity in human hepatocytes","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118330","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"118330"}}